Ipca Laboratories Ltd.
BSE: 524494 | Sector: Health care |
NSE: IPCALAB | ISIN Code: INE571A01038 |
BSE 12:05 | 09 Feb | 874.85 |
8.25 (0.95%) |
OPEN
883.70 |
HIGH
889.00 |
LOW
871.85 |
NSE 11:54 | 09 Feb | 873.60 |
7.25 (0.84%) |
OPEN
873.00 |
HIGH
889.95 |
LOW
868.60 |
OPEN | 883.70 |
PREVIOUS CLOSE | 866.60 |
VOLUME | 8974 |
52-Week high | 1089.00 |
52-Week low | 830.00 |
P/E | 34.67 |
Mkt Cap.(Rs cr) | 22,195 |
Buy Price | 873.75 |
Buy Qty | 1.00 |
Sell Price | 874.85 |
Sell Qty | 2.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Ipca Laboratories Ltd. (IPCALAB) - Balance Sheet
Figures in Rs crore | 2022 | 2021 | 2020 |
Sources of Funds | |||
Share Capital | 25.37 | 25.37 | 25.27 |
Reserves | 5497.97 | 4727.35 | 3652.27 |
Total Shareholders Funds | 5523.34 | 4752.72 | 3677.54 |
Secured Loans | 554.57 | 113.53 | 298.19 |
Unsecured Loans | 264.81 | 162.16 | 209.50 |
Total Debt | 819.38 | 275.69 | 507.69 |
Total Liabilities | 6342.72 | 5028.41 | 4185.23 |
Application of Funds | |||
Gross Block | 3276.06 | 2899.27 | 2688.79 |
Capital Work in Progress | 289.04 | 182.00 | 84.19 |
Investments | 1447.52 | 867.84 | 648.72 |
Current Assets, Loans & Advances | |||
Inventories | 1750.15 | 1517.09 | 1266.96 |
Sundry Debtors | 815.94 | 774.46 | 839.13 |
Cash and Bank | 592.97 | 306.92 | 152.40 |
Loans and Advances | 581.96 | 581.66 | 437.70 |
Total Current Assets | 3741.02 | 3180.13 | 2696.19 |
Current Liabilities and Provisions | |||
Current Liabilities | 1103.25 | 957.01 | 985.24 |
Provisions | 116.39 | 113.15 | 99.60 |
Net Current Assets | 2521.38 | 2109.97 | 1611.35 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | N/A | N/A | N/A |
Deferred Tax Liability | N/A | N/A | N/A |
Net Deferred Tax | N/A | N/A | N/A |
Other Assets | 0.00 | 0.00 | 0.00 |
Total Assets | 6342.72 | 5028.41 | 4185.23 |
Quick Links for Ipca Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices